🇺🇸 FDA
Patent

US 8440202

Induction of an immune response against dengue virus using the prime-boost approach

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 8440202 (Induction of an immune response against dengue virus using the prime-boost approach) held by United States of America as represented by the Secretary of the Air Force expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/53